- Investing Ideas
- U.S. Healthcare Undervalued based on future growth
U.S. Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
Humana
Market Cap: US$27.6b
Provides medical and specialty insurance products in the United States.
HUM
US$243.12
7D
11.8%
1Y
-7.3%
CONMED
Market Cap: US$1.1b
A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
CNMD
US$35.96
7D
-6.6%
1Y
-26.8%
Nutex Health
Market Cap: US$802.0m
Operates as a healthcare services and operations company in the United States.
NUTX
US$112.02
7D
3.3%
1Y
1.9%
Embecta
Market Cap: US$516.4m
A medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.
EMBC
US$8.71
7D
-4.8%
1Y
-29.1%
Auna
Market Cap: US$391.5m
A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.
AUNA
US$5.11
7D
-1.9%
1Y
-26.0%
CareCloud
Market Cap: US$135.1m
A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$2.97
7D
-7.2%
1Y
62.3%
OptimizeRx
Market Cap: US$114.8m
Operates as a digital healthcare technology company.
OPRX
US$6.14
7D
-4.2%
1Y
-36.3%